316 related articles for article (PubMed ID: 35083973)
1. The egyptian clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease.
Fouad Y; Esmat G; Elwakil R; Zakaria S; Yosry A; Waked I; El-Razky M; Doss W; El-Serafy M; Mostafa E; Anees M; Sakr MA; AbdelAty N; Omar A; Zaki S; Al-Zahaby A; Mahfouz H; Abdalla M; Albendary M; Hamed AK; Gomaa A; Hasan A; Abdel-Baky S; El Sahhar M; Shiha G; Attia D; Saeed E; Kamal E; Bazeed S; Mehrez M; Abdelaleem S; Gaber Y; Abdallah M; Salama A; Tawab DA; Nafady S
Saudi J Gastroenterol; 2022; 28(1):3-20. PubMed ID: 35083973
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and risk factors of metabolic associated fatty liver disease among people living with HIV in China.
Liu D; Shen Y; Zhang R; Xun J; Wang J; Liu L; Steinhart C; Chen J; Lu H
J Gastroenterol Hepatol; 2021 Jun; 36(6):1670-1678. PubMed ID: 33140878
[TBL] [Abstract][Full Text] [Related]
3. Position statement on the diagnosis and management of non-alcoholic fatty liver disease.
Alswat KA; Fallatah HI; Al-Judaibi B; Elsiesy HA; Al-Hamoudi WK; Qutub AN; Alturaify N; Al-Osaimi A
Saudi Med J; 2019 Jun; 40(6):531-540. PubMed ID: 31219486
[TBL] [Abstract][Full Text] [Related]
4. The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease.
Eslam M; Sarin SK; Wong VW; Fan JG; Kawaguchi T; Ahn SH; Zheng MH; Shiha G; Yilmaz Y; Gani R; Alam S; Dan YY; Kao JH; Hamid S; Cua IH; Chan WK; Payawal D; Tan SS; Tanwandee T; Adams LA; Kumar M; Omata M; George J
Hepatol Int; 2020 Dec; 14(6):889-919. PubMed ID: 33006093
[TBL] [Abstract][Full Text] [Related]
5. Validation of a Non-Laboratory Based Screening Tool for Predicting Non-Alcoholic Fatty Liver Disease in an Egyptian Setting.
Abd El-Wahab EW; Zein El-Abedin RA; Ahmed WM; Shatat HZ
Am J Med Sci; 2020 Dec; 360(6):662-677. PubMed ID: 32739036
[TBL] [Abstract][Full Text] [Related]
6. A Review of the Increasing Prevalence of Metabolic-Associated Fatty Liver Disease (MAFLD) in Children and Adolescents Worldwide and in Mexico and the Implications for Public Health.
Ramírez-Mejía MM; Díaz-Orozco LE; Barranco-Fragoso B; Méndez-Sánchez N
Med Sci Monit; 2021 Aug; 27():e934134. PubMed ID: 34456329
[TBL] [Abstract][Full Text] [Related]
7. Comparison of MAFLD and NAFLD diagnostic criteria in real world.
Lin S; Huang J; Wang M; Kumar R; Liu Y; Liu S; Wu Y; Wang X; Zhu Y
Liver Int; 2020 Sep; 40(9):2082-2089. PubMed ID: 32478487
[TBL] [Abstract][Full Text] [Related]
8. Nomenclature and definition of metabolic-associated fatty liver disease: a consensus from the Middle East and north Africa.
Shiha G; Alswat K; Al Khatry M; Sharara AI; Örmeci N; Waked I; Benazzouz M; Al-Ali F; Hamed AE; Hamoudi W; Attia D; Derbala M; Sharaf-Eldin M; Al-Busafi SA; Zaky S; Bamakhrama K; Ibrahim N; Ajlouni Y; Sabbah M; Salama M; Anushiravani A; Afredj N; Barakat S; Hashim A; Fouad Y; Soliman R
Lancet Gastroenterol Hepatol; 2021 Jan; 6(1):57-64. PubMed ID: 33181119
[TBL] [Abstract][Full Text] [Related]
9. Updates in fatty liver disease: Pathophysiology, diagnosis and management.
Gofton C; George J
Aust J Gen Pract; 2021 Oct; 50(10):702-707. PubMed ID: 34590082
[TBL] [Abstract][Full Text] [Related]
10. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases.
Chalasani N; Younossi Z; Lavine JE; Charlton M; Cusi K; Rinella M; Harrison SA; Brunt EM; Sanyal AJ
Hepatology; 2018 Jan; 67(1):328-357. PubMed ID: 28714183
[No Abstract] [Full Text] [Related]
11. Prevalence of and risk factors for metabolic associated fatty liver disease in an urban population in China: a cross-sectional comparative study.
Chen YL; Li H; Li S; Xu Z; Tian S; Wu J; Liang XY; Li X; Liu ZL; Xiao J; Wei JY; Ma CY; Wu KN; Ran L; Kong LQ
BMC Gastroenterol; 2021 May; 21(1):212. PubMed ID: 33971822
[TBL] [Abstract][Full Text] [Related]
12. Metabolic dysfunction-associated fatty liver disease - How relevant is this to primary care physicians and diabetologists?
Lee CH
Prim Care Diabetes; 2022 Apr; 16(2):245-251. PubMed ID: 35086794
[TBL] [Abstract][Full Text] [Related]
13. Metabolic Dysfunction-associated Fatty Liver Disease and Mortality Among Chinese Adults: a Prospective Cohort Study.
Wang X; Wu S; Yuan X; Chen S; Fu Q; Sun Y; Lan Y; Hu S; Wang Y; Lu Y; Qu S; Wang L
J Clin Endocrinol Metab; 2022 Jan; 107(2):e745-e755. PubMed ID: 34467980
[TBL] [Abstract][Full Text] [Related]
14. [Introduction to the APASL clinical guidelines on the management of metabolic-associated fatty liver disease].
Shi YW; Xiao QQ; Fan JG
Zhonghua Gan Zang Bing Za Zhi; 2020 Nov; 28(11):915-917. PubMed ID: 33256275
[TBL] [Abstract][Full Text] [Related]
15. Metabolic-associated fatty liver disease and autoimmune hepatitis: an overlooked interaction.
Gaber Y; AbdAllah M; Salama A; Sayed M; Abdel Alem S; Nafady S
Expert Rev Gastroenterol Hepatol; 2021 Oct; 15(10):1181-1189. PubMed ID: 34263707
[TBL] [Abstract][Full Text] [Related]
16. The prevalence of metabolic associated fatty liver detected by FibroScan® in women with gestational diabetes in a multiethnic population.
Deng D; George J; Pasupathy D; Wah Cheung N
Diabetes Res Clin Pract; 2021 Apr; 174():108757. PubMed ID: 33744378
[TBL] [Abstract][Full Text] [Related]
17. Too much medicine: overdiagnosis and overtreatment of non-alcoholic fatty liver disease.
Rowe IA
Lancet Gastroenterol Hepatol; 2018 Jan; 3(1):66-72. PubMed ID: 29254617
[TBL] [Abstract][Full Text] [Related]
18. Impact of renaming NAFLD to MAFLD in an Australian regional cohort: Results from a prospective population-based study.
Kemp W; Clayton-Chubb D; Majeed A; Glenister KM; Magliano DJ; Lubel J; Bourke L; Simmons D; Roberts SK
J Gastroenterol Hepatol; 2022 Feb; 37(2):395-403. PubMed ID: 34693553
[TBL] [Abstract][Full Text] [Related]
19. Circulating angiopoietin-like proteins in metabolic-associated fatty liver disease: a systematic review and meta-analysis.
Ke Y; Liu S; Zhang Z; Hu J
Lipids Health Dis; 2021 May; 20(1):55. PubMed ID: 34034750
[TBL] [Abstract][Full Text] [Related]
20. MAFLD vs. NAFLD: shared features and potential changes in epidemiology, pathophysiology, diagnosis, and pharmacotherapy.
Xian YX; Weng JP; Xu F
Chin Med J (Engl); 2020 Dec; 134(1):8-19. PubMed ID: 33323806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
